303 related articles for article (PubMed ID: 17092340)
1. Regulation of CDK4.
Bockstaele L; Coulonval K; Kooken H; Paternot S; Roger PP
Cell Div; 2006 Nov; 1():25. PubMed ID: 17092340
[TBL] [Abstract][Full Text] [Related]
2. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".
Bockstaele L; Kooken H; Libert F; Paternot S; Dumont JE; de Launoit Y; Roger PP; Coulonval K
Mol Cell Biol; 2006 Jul; 26(13):5070-85. PubMed ID: 16782892
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
4. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
5. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.
Colleoni B; Paternot S; Pita JM; Bisteau X; Coulonval K; Davis RJ; Raspé E; Roger PP
Oncogene; 2017 Jul; 36(30):4349-4361. PubMed ID: 28368408
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, using a series of monoclonal antibodies.
Lukas C; Jensen SK; Bartkova J; Lukas J; Bartek J
Hybridoma; 1999 Jun; 18(3):225-34. PubMed ID: 10475236
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
Roskoski R
Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
[TBL] [Abstract][Full Text] [Related]
10. Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes.
Gonzales AJ; Goldsworthy TL; Fox TR
Carcinogenesis; 1998 Jun; 19(6):1093-102. PubMed ID: 9667749
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D-cdk6 complex is targeted by p21(WAF) in growth-arrested lymphoma cells.
Tvrdík D; Djaborkhel R; Nagy A; Eckschlager T; Raska I; Müller J
J Struct Biol; 2002; 140(1-3):49-56. PubMed ID: 12490153
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
14. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis.
Coulonval K; Bockstaele L; Paternot S; Dumont JE; Roger PP
Exp Cell Res; 2003 Nov; 291(1):135-49. PubMed ID: 14597415
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic stimulation recruits cyclin-dependent kinase in the cell cycle start in rat fibroblast.
Jinno S; Hung SC; Yamamoto H; Lin J; Nagata A; Okayama H
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13197-202. PubMed ID: 10557297
[TBL] [Abstract][Full Text] [Related]
16. All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin-dependent kinases.
Kosaka C; Sasaguri T; Komiyama Y; Takahashi H
Hypertens Res; 2001 Sep; 24(5):579-88. PubMed ID: 11675954
[TBL] [Abstract][Full Text] [Related]
17. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
[TBL] [Abstract][Full Text] [Related]
18. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
19. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.
Topacio BR; Zatulovskiy E; Cristea S; Xie S; Tambo CS; Rubin SM; Sage J; Kõivomägi M; Skotheim JM
Mol Cell; 2019 May; 74(4):758-770.e4. PubMed ID: 30982746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
